CD8A and neoplasm: Py8119 cells with Axl knockdown (by the CRISPR technology) transplanted into naive C57Bl/6 mice showed sensitivity to immunotherapy, delayed tumor growth, increased expression of MHC-I molecules and enhanced infiltration of mature DCs, CD4+ T cells, and CD8+ T cells in the tumor tissue (84).